Hepatitis B in a pediatric hemodialysis unit.
Serial HB Ag determinations were obtained on 62 children undergoing hemodialysis during a 31/2-year period. Thirty six (58%) of the patients had atleast one positive HB Ag determination (titer larger than 1:8) either during the period of dialysis or within 2 months after transplantation. Of the children who became HB Ag positive during the period of dialysis, 89% demonstrated hepatitis B antigenemia during the initial 6 months of dialysis. Becuase of the temporal relationship between the development of HB Ag positivity and the duration of dialysis, contamination of equipment was proposed as a contributing source for transmission of HB Ag. Although 67% of the patients who were HB Ag positive during dialysis developed biochemical evidence of hepatic dysfunction, only two patients had clinical manifestations. The incidence of hepatic involvement appeared to be related to age; only one of nine children less than 12 years of age had evidence of hepatic disease. Intermittent persistence of HB Ag for periods larger than 3 years was observed. Both the incidence and persistence of HB Ag indicate the need to prevent its acquisition by pediatric patients undergoing hemodialysis.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000032:analysis; D000985:Antisepsis; D001219:Aspartate Aminotransferases / Q000032:analysis; D002140:California; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000635:transmission; D006506:Hepatitis A / Q000453:epidemiology* / Q000635:transmission; D006511:Hepatitis B Antigens / Q000032:analysis*; D006757:Hospital Units; D006801:Humans; D016030:Kidney Transplantation; D008099:Liver / Q000503:physiopathology; D010564:Personnel, Hospital; D006435:Renal Dialysis; D014184:Transplantation, Homologous
D006511:Hepatitis B Antigens; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase